Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about LEXX
Recent news which mentions LEXX
< Previous
1
2
3
4
Next >
Lexaria Aims To Demonstrate DehydraTECH's Performance In Epilepsy Research
April 11, 2022
Tickers
LEXX
Tags
Markets
Cannabis
Market News
From
Benzinga
Lexaria Bioscience's 24th Patent Sets Stage For Market Opportunities In Australia
March 31, 2022
Tickers
LEXX
Tags
Biotech
InvestorBrandNetwork
Market News
From
Benzinga
Lexaria Bioscience Optimistic About Upcoming Hypertension Study
March 28, 2022
Tickers
LEXX
Tags
Penny Stocks
General
LEXX
From
Benzinga
Lexaria's IP Portfolio Grows Following Receipt Of 24th Granted Patent
March 22, 2022
Tickers
LEXX
Tags
Benzinga
General
LEXX
From
Benzinga
Lexaria Bioscience Commences DehydraTECH-CBD Epilepsy Research Program
March 16, 2022
Tickers
LEXX
LEXXW
Tags
Market News
Penny Stocks
Benzinga
From
Benzinga
Lexaria Bioscience Receives Award For Oral Nicotine Compound Patent
March 09, 2022
Tickers
LEXX
Tags
Penny Stocks
Benzinga
General
From
Benzinga
Studies Advance Lexaria Bioscience's Tech For Improving Pharmaceutical Drugs
March 07, 2022
Tickers
LEXX
Tags
Partner Content
Market News
Biotech
From
Benzinga
Lexaria's DehydraTECH(TM) Demonstrates Faster Delivery Of Sildenafil
March 04, 2022
Tickers
LEXX
TM
Tags
Partner Content
Market News
Biotech
From
Benzinga
Lexaria Bioscience Optimistic Of Positive Study Results
February 28, 2022
Tickers
LEXX
Tags
Cannabis
Markets
Market News
From
Benzinga
Lexaria Optimistic About Expanded DehydraTECH Investigations
February 23, 2022
Tickers
LEXX
Tags
Biotech
InvestorBrandNetwork
Partner Content
From
Benzinga
Lexaria World Leader Through DehydraTECH(TM) – Its Pioneering Drug Delivery Tech
February 22, 2022
Tickers
LEXX
TM
Tags
Market News
Partner Content
Markets
From
Benzinga
Following Sildenafil Study, Lexaria Announces Plans For More Studies In 2022
February 17, 2022
Tickers
LEXX
Tags
InvestorBrandNetwork
Biotech
Partner Content
From
Benzinga
Lexaria's DehydraTECH(TM) To Be Evaluated As Treatment For Multiple Conditions
February 14, 2022
Tickers
LEXX
TM
Tags
LEXX
General
Benzinga
From
Benzinga
Lexaria Technology Shows Promise In Improving Performance Of ED Drugs
February 11, 2022
Tickers
LEXX
Tags
Partner Content
Market News
Biotech
From
Benzinga
Lexaria CEO Summarizes 2021 Milestones in Letter to Shareholders
February 09, 2022
Tickers
LEXX
Tags
LEXX
General
Biotech
From
Benzinga
Lexaria Bioscience Announces Significant Findings From Sildenafil Animal Study
February 03, 2022
Tickers
LEXX
Tags
General
LEXX
Benzinga
From
Benzinga
Lexaria CEO Offers A Glimpse Into Company's Unique Tech On EDGE Podcast
February 01, 2022
Tickers
LEXX
Tags
Benzinga
General
LEXX
From
Benzinga
Lexaria Emphasizes Oral Cannabinoid Benefits Following SARS-CoV-2 Study
January 28, 2022
Tickers
LEXX
Tags
InvestorBrandNetwork
Partner Content
LEXX
From
Benzinga
Lexaria Bioscience Marks Great Start to its 2022 R&D Programs
January 21, 2022
Tickers
LEXX
Tags
Benzinga
Penny Stocks
Markets
From
Benzinga
Lexaria Bioscience Comments on Study Examining Cannabinoids and SARS-CoV-2
January 19, 2022
Tickers
LEXX
Tags
Partner Content
Biotech
LEXX
From
Benzinga
Lexaria Bioscience Leveraging DehydraTECH(TM) for More Effective Oral Medicine
January 18, 2022
Tickers
LEXX
TM
Tags
Benzinga
Penny Stocks
Markets
From
Benzinga
Lexaria Bioscience Celebrates Productive Year for Blood Pressure Drug Solution
January 12, 2022
Tickers
LEXX
Tags
Market News
Markets
Cannabis
From
Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Receives Independent Review Board Approval for Human Study
January 11, 2022
Tickers
LEXX
Tags
Penny Stocks
General
LEXX
From
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 07, 2022
Tickers
ATOS
AXSM
CFRX
ENSC
Tags
IKNA
GRPH
LEXX
From
Benzinga
Lexaria Bioscience Increases Investor Visibility with SRAX
January 07, 2022
Tickers
LEXX
SRAX
Tags
General
LEXX
Benzinga
From
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 06, 2022
Tickers
ATOS
BVXV
CEMI
CFRX
Tags
SXTC
Movers
CFRX
From
Benzinga
Lexaria Bioscience Announces Approval from Independent Review for DehydraTECH-CBD Study
December 30, 2021
Tickers
LEXX
Tags
Health Care
LEXX
General
From
Benzinga
Lexaria Bioscience Expects Study Results to Show Patented Tech's Value in Treating Hypertension
December 28, 2021
Tickers
LEXX
Tags
Benzinga
Penny Stocks
Market News
From
Benzinga
Lexaria Bioscience Announces Major Discovery; Increasing Effectiveness of Orally Administered CBD
December 23, 2021
Tickers
LEXX
Tags
Penny Stocks
Benzinga
Market News
From
Benzinga
Lexaria's DehydraTECH(TM) CBD Found to Reduce Arterial Stiffness in Study
December 17, 2021
Tickers
LEXX
TM
Tags
Market News
Penny Stocks
Benzinga
From
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.